This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
iPad-based solution for ePRO entered in first ever contest for software applications that focus on maximizing engagement and value for patients enrolled in clinical trials.
Cranford, NJ (PRWEB) February 25, 2014
WriteResult, a leading provider of clinical data management solutions, announced today that it is participating in the first ever Patient Engagement App Challenge a contest sponsored by Lilly, UBC, Enlight Biosciences and Partnerships in Clinical Trials to stimulate development of technology-driven solutions focused on engaging patients in the clinical trial process. WriteResult is showcasing its latest and highly anticipated ePRO application, myPROpad.
"The move toward a patient-centered strategy in pharmaceutical development is finally getting the attention it deserves," states Karen Briegs, VP of Sales and Marketing when asked why myPROpad was entered, "and companies that embrace this philosophy are seeing success. In fact, almost 25 percent of the treatment-benefit claims granted by the FDA between 2006 and 2010 were based on PROMs and this number will continue to grow." WriteResult President Peter Oudheusden adds, "Collecting PRO data is the ultimate in patient engagement as the entire focus of this effort is tuned-in to hearing directly from the patient how they are feeling. We felt it was important to honor that data and to take that very personal interaction one step further by providing the patient with a tool that makes data collection easy and fun, and that gives value in return."
myPROpad uses the exceptional capabilities of an iPad to deliver questionnaires, surveys and other assessments to a patient through a large, crisp, intuitive touchscreen interface. The most recent release of myPROpad includes new functionality to present interactive educational material to a patient, and to capture appreciation credits for completed assessments that can be used to stimulate friendly competition or be tied to e-commerce sites.
myPROpad has much to offer the patient, but was also created to simplify PRO data collection for sites and sponsors. One iPad can support any number of patients and trials, and data transfers are completely built into the site workflow making it easy to use no matter where the coordinator has to travel to see patients. Sponsors benefit from the ease of study startup because myPROpad transforms already approved and validated paper assessments into electronic forms that retain the same layout and formatting as the original so there is no ePRO screen development or risk of non-equivalency like other products available today.
"WriteResult has made study participation interesting and motivating, which ultimately leads to engaged patients who are compliant with study procedures and who provide data that sponsors can rely on to drive advancements in medicine and their business," says Ms. Briegs. "We are committed to helping make ePRO accessible and easy for sponsors, sites and for our patients and we believe myPROpad is the way to do it!"
You can join in helping myPROpad win the Patient Engagement competition by voting here.
For more information on myPROpad, visit http://www.mypropad.com or contact Karen Briegs at (908) 272-4787.
WriteResult offers full-service data management solutions for clinical research through the collection and verification of ePROs leveraging digital pen and paper technology. Since 2006 WriteResult has partnered with study sponsors to deliver a simple and effective ePRO solution rapid study startup with clean, real-time data using a technology thats intuitive for sites and patients.
For more information about WriteResult, please email solutions(at)writeresult(dot)com or call (908) 272-4787.
iPad is a registered trademark of Apple, Inc.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11614015.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
WISTV License Subsidiary, LCC
1111 Bull St.